Literature DB >> 6185783

alpha- and beta-blockade with labetalol in acute myocardial infarction.

G I Nelson, R C Ahuja, M Hussain, B Silke, S H Taylor.   

Abstract

On the hypothesis that the addition of alpha-blockade would mitigate the haemodynamic disadvantages of beta-blockade alone in the early stages of uncomplicated acute myocardial infarction, 15 patients were studied during the intravenous infusion of labetalol (0.5 mg/kg/h). The mean systemic arterial pressure was reduced by an average of 15 mm Hg. In the nine patients haemodynamically evaluated, the cardiac output (thermal dilution) was reduced without change in the heart rate or left heart filling pressure (pulmonary artery occluded pressure); left ventricular stroke work was significantly decreased. The reduction in these major determinants of myocardial oxygen consumption suggests that the combination of alpha- and beta-blockade may be haemodynamically advantageous in normotensive patients in the early stages of uncomplicated acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185783     DOI: 10.1097/00005344-198211000-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation.

Authors:  G Krumpl; H Todt; K Krejcy; G Raberger
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?

Authors:  B Silke; S P Verma; R C Ahuja; M Hussain; M Hafizullah; G Reynolds; G I Nelson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Combined receptor intervention and myocardial infarction.

Authors:  D A Chamberlain; R Vincent
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.